Motiva Implants

What Motiva Implants does

Motiva Implants, operated by Establishment Labs, is a Costa Rica-headquartered women's health company that designs, manufactures, and sells silicone gel breast implants, tissue expanders, and gluteal implants globally. Founded in 2008 and headquartered in Alajuela, the company sells exclusively through a certified surgeon network across more than 80 countries, with a dedicated US market site (motivausa.com). Its portfolio spans the Motiva Round, Ergonomix, and Ergonomix2/JOY implant lines, the Flora tissue expander for reconstruction, and the GlutealArmonic implant, supported by integrated surgical solutions such as MotivaHybrid (implant plus fat grafting), Motiva MinimalScar, Preservé, and the Aesthetic BreastRecon platform.

The company's differentiation rests on a stack of proprietary technologies: the SmoothSilk/SilkSurface bioengineered shell surface, ProgressiveGel Ultima and Contour gel formulations, TrueMonobloc shell-gel interphase engineering, BluSeal barrier-layer visualization, and the optional Qid RFID microtransponder embedded in the cohesive gel for non-invasive post-implant verification. Motiva reports a sub-1% complication rate (capsular contracture and rupture) across more than one million implants, with over 2.5 million RFID-enabled units placed since 2014. Its SmoothSilk surface has been independently evaluated in a 2021 Nature Biomedical Engineering study from MIT's Langer Lab, which compared immune response across six breast implant brands.

Revenue is generated primarily through hardware sales of implants and tissue expanders to certified surgeons and medical facilities, supplemented by consumer-paid extended warranty programs priced at $100-$200 USD per multi-year contract (2Y or 5Y). Patient engagement is supported by the MotivaImagine digital platform for implant registration and warranty management, the Center Locator surgeon-matching tool, and the ELSA patient support service. The company has received FDA Premarket Approval (PMA) for its Augmentation Indication products and holds CE Mark, ISO 10993-1 biocompatibility certification, MR Conditional labeling for its RFID-enabled implants, and Carbon Neutral certification for its manufacturing facilities.

Name

Motiva Implants

Legal name

Establishment Labs

Website

https://motiva.health

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Motiva Implants, operated by Establishment Labs, designs and manufactures silicone breast implants, tissue expanders, and gluteal implants with proprietary surface and RFID technologies, selling through a global certified surgeon network serving aesthetic and reconstruction patients.

Ownership category

akta.pro rank

Product category

Breast Implants and Reconstructive Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

• Silicone breast implants
• Breast reconstruction devices
• Tissue expanders
• RFID implant verification
• Cosmetic surgery medical devices

Headquarters

HQ city

Alajuela

HQ country

Costa Rica

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Breast Implants and Medical Devices: Sale of silicone breast implants, tissue expanders, and gluteal implants to certified surgeons and medical facilities worldwide.
2. Extended Warranty Programs: Motiva offers extended warranty programs (2Y and 5Y) that provide financial assistance and product replacement in case of rupture or capsular contracture Baker grades III and IV. Registration required within 90 days post-surgery.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Motiva Implants (operated by Establishment Labs) manufactures and sells silicone gel breast implants, tissue expanders, and gluteal implants through a global network of certified plastic surgeons. The company complements its medical devices with the MotivaImagine® digital platform for implant registration and warranty management, and offers extended warranty programs covering rupture and capsular contracture.

Product overview

Motiva Implants is a women's health company specializing in breast augmentation and reconstruction medical devices. Their product portfolio centers on silicone breast implants (Motiva® Round, Ergonomix®, Ergonomix2®/JOY®), tissue expanders (Flora®), and buttock implants (GlutealArmonic®). The company offers proprietary technologies including SmoothSilk® bioengineered surface, RFID implant verification (Qid®), and proprietary gel technologies (Ultima®, ProgressiveGel® Contour). Beyond standalone implants, Motiva provides integrated surgical solutions including MotivaHybrid® (implant + fat grafting), Motiva MinimalScar®, and Aesthetic BreastRecon™. These are supported by digital platforms for implant registration (MotivaImagine®), surgeon matching (Center Locator), and patient support (ELSA). The portfolio also includes comprehensive warranty programs and patient education resources.

Differentiator

Problem solved

Functional benefit

Brands

• Ergonomix®: The World's First Ergonomic Breast Implant designed to mimic the look, feel, and movement of natural breast tissue.
• Motiva® Round
• GlutealArmonic®
• Qid®
• RFID Technology
• MotivaHybrid®
• Flora® Tissue Expander
• Aesthetic BreastRecon™
• MotivaImagine®
• Motiva MinimalScar®
• Preservé™

Products and services

• Motiva® Round Round silicone breast implant providing high projection, balanced firmness, and complete filling of the upper pole for a youthful appearance. Sold to certified plastic surgeons for breast augmentation procedures.
• Motiva Ergonomix® World's first ergonomic silicone breast implant using ProgressiveGel Ultima® and TrueMonobloc® technology to mimic natural breast movement—round shape when lying, teardrop when standing. FDA Premarket Approval (PMA) granted for augmentation indication.
• Motiva Ergonomix2® (JOY®) Next-generation ergonomic breast implant designed for natural look and feel, adapting to natural movement of the body. Sold through certified surgeons for breast augmentation.
• Flora® Tissue Expander Next-generation tissue expander used in two-stage breast reconstruction to prepare the breast area for subsequent permanent implant placement. Sold to reconstructive surgeons and medical facilities.
• GlutealArmonic® Smooth-surfaced gluteal (buttock) implant with harmonic shape filled with ProgressiveGel® Contour, designed for augmenting and sculpting the gluteal area for a natural-looking appearance. Sold through certified plastic surgeons.
• MotivaImagine® Platform Digital platform and mobile app (iOS/Android) that enables patients to register their implants, manage their device information, and purchase extended warranty programs. Available globally.
• Always Confident Warranty Free base warranty included with every Motiva® implant, covering rupture due to manufacturing defect and offering product replacement against capsular contracture Baker grades III and IV for 10 years.
• 2-Year Motiva® Program (without Qid®) Optional extended warranty priced at $100 USD that covers rupture or capsular contracture Baker grades III and IV for two years, including up to $1,000 USD financial assistance for revision surgery.
• 5-Year Motiva® Program (with Qid®) Optional extended warranty priced at $200 USD that covers rupture or capsular contracture Baker grades III and IV for five years, including product replacement and up to $2,500 USD financial assistance for revision surgery. Requires Qid® RFID-enabled implant.

Quantifiable outcome

• Less than 1% complication rate for capsular contracture and rupture in over 1 million implants worldwide
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core and supporting.

• MIT Professor Langer LabcoreStrategic or Co-development Partner · 1 January 2021Research collaboration with MIT's Professor Langer Lab resulted in a study published in Nature Biomedical Engineering (2021) comparing immune response to 6 breast implant brands. Study demonstrated Motiva's SmoothSilk® surface shows improved biocompatibility compared to all other surfaces tested.
• Puregraft®supportingTechnology or IntegrationPuregraft® selective closed-system design is recommended for fat grafting processing in MotivaHybrid® procedures, enabling safer and more sterile fat processing for combined implant and fat transfer procedures.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Regional players

• HansBiomed: South Korean breast implant and aesthetics manufacturer, primarily serving Asian markets where Motiva's surgeon network is thinner, representing regional rather than direct global overlap.
• Silimed: Brazilian silicone implant manufacturer historically strong in the Latin American aesthetic market where Motiva also has significant presence, with overlapping surgeon relationships in Brazil.

Direct peers

• POLYTECH Health & Aesthetics: German manufacturer of silicone breast implants and tissue expanders with broad international distribution that competes head-to-head with Motiva in Europe, Latin America and other ex-US markets.
• Mentor Worldwide (Johnson & Johnson MedTech): Johnson & Johnson's breast implant business (MemoryGel®, MemoryShape®, CPGT™ tissue expanders) is the second pillar of the US market and the other direct incumbent Motiva must displace, with deeply entrenched plastic surgeon relationships.
• Sientra: US-focused breast implant and tissue expander manufacturer (OPUS®) with comparable surgeon-channel GTM and FDA-approved silicone gel implants, making it the closest US-headquartered direct competitor in size and category.
• Allergan Aesthetics (AbbVie): AbbVie's aesthetics division manufactures Natrelle silicone breast implants and is the long-standing US market leader that Motiva is directly competing against post-FDA approval, with similar surgeon-channel distribution and product portfolio overlap.
• Ideal Implant: Structured saline-filled breast implant company that received FDA approval in 2014, pursuing a similar challenger positioning against Allergan and Mentor in the US aesthetic implant market.
• Sebbin: French breast implant manufacturer with a broad silicone implant portfolio, selling into many of the same international aesthetic markets where Motiva competes.
• GC Aesthetics: Ireland-based breast implant manufacturer (Nagor®, Eurosilicone®) with global distribution and a similarly broad portfolio of round, anatomical and tissue expander products aimed at plastic surgeons.

Broad incumbents

• Integra LifeSciences: Diversified medical device company with adjacent surgical and regenerative product lines that occasionally touches implant categories, illustrating the broader-incumbent profile Motiva lacks and which limits its ability to bundle across procedural specialties.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCu8wk0NFGk1R13iBSdXRCLg?view_as=subscriber
• Facebookfacebook.com/motivaimplants
• Instagraminstagram.com/motivaimplants
• LinkedInlinkedin.com/company/motiva-implants

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Motiva Implants